Clinical Trial Update: Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin, pemetrexed, atezolizumab, and bevacizumab in chemotherapy- and immunotherapy-naïve patients with stage IV non-squamous non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Nasser Hanna | Conditions: NSCLC Stage IV, NSCLC, Recurrent | Phase 2 | Status: TERMINATED | Results posted: 2023-03-01